Biomarkers in EndoVascular Aneurysm Repair (EVAR) and Abdominal Aortic Aneurysm: Pathophysiology and Clinical Implications

Overview

Journal Diagnostics (Basel)

Specialty Radiology

Date 2022 Jan 21

PMID 35054350

Authors

Francesco Stilo

Vincenzo Catanese

Antonio Nenna

Nunzio Montelione

Francesco Alberto Codispoti

Emanuele Verghi

Teresa Gabellini

Mohamad Jawabra

Massimo Chello

Francesco Spinelli

Affiliations

Soon will be listed here.

Abstract

Circulating biomarkers have been recently investigated among patients undergoing endovascular aortic aneurysm repair (EVAR) for abdominal aortic aneurysm (AAA). Considering the plethora of small descriptive studies reporting potential associations between biomarkers and clinical outcomes, this review aims to summarize the current literature considering both the treated disease (post EVAR) and the untreated disease (AAA before EVAR). All studies describing outcomes of tissue biomarkers in patients undergoing EVAR and in patients with AAA were included, and references were checked for additional sources. In the EVAR scenario, circulating interleukin-6 (IL-6) is a marker of inflammatory reaction which might predict postoperative morbidity; cystatin C is a promising early marker of post-procedural acute kidney injury; plasma matrix metalloproteinase-9 (MMP-9) concentration after 3 months from EVAR might help in detecting post-procedural endoleak. This review also summarizes the current gaps in knowledge and future direction of this field of research. Among markers used in patients with AAA, galectin and granzyme appear to be promising and should be carefully investigated even in the EVAR setting. Larger prospective trials are required to establish and evaluate prognostic models with highest values with these markers.

Citing Articles

overexpression alleviates oxidative stress-induced ferroptosis in aortic aneurysms via activation.

He Y, Wang X, Li D, Zhu Q, Xiang Y, He Y J Thorac Dis. 2024; 16(4):2510-2527.

PMID: 38738239 PMC: 11087628. DOI: 10.21037/jtd-24-370.

Preoperative Immature Neutrophils Predict Clinical Outcomes in Patients with Uncomplicated Type-B Aortic Dissection After Thoracic Endovascular Aortic Repair.

Abu Bokha A, Li C, Song M, Wei X, Li R Int J Gen Med. 2023; 16:3637-3644.

PMID: 37637713 PMC: 10455952. DOI: 10.2147/IJGM.S414567.

NADPH Oxidases in Aortic Aneurysms.

Salmon M Antioxidants (Basel). 2022; 11(9).

PMID: 36139902 PMC: 9495752. DOI: 10.3390/antiox11091830.

References

Davis F, Rateri D, Daugherty A . Abdominal aortic aneurysm: novel mechanisms and therapies. Curr Opin Cardiol. 2015; 30(6):566-73. PMC: 4624089. DOI: 10.1097/HCO.0000000000000216. View

LeMaire S, Wang X, Wilks J, Carter S, Wen S, Won T . Matrix metalloproteinases in ascending aortic aneurysms: bicuspid versus trileaflet aortic valves. J Surg Res. 2005; 123(1):40-8. DOI: 10.1016/j.jss.2004.06.007. View

Ascoli Marchetti A, Pratesi G, Giulio L, Battistini M, Massoud R, Ippoliti A . EVAR and OPEN treatment of abdominal aortic aneurysm: What is the role of MMP-9 in the follow-up?. J Med Vasc. 2017; 42(1):21-28. DOI: 10.1016/j.jdmv.2017.01.004. View

Ilic N, Opacic D, Mutavdzic P, Koncar I, Dragas M, Jovicic S . Evaluation of the renal function using serum Cystatin C following open and endovascular aortic aneurysm repair. Vascular. 2017; 26(2):132-141. DOI: 10.1177/1708538117717348. View

Kapetanios D, Karkos C, Papazoglou K . Changes in circulating markers of coagulation and fibrinolysis after EVAR. Int Angiol. 2018; 37(6):444-450. DOI: 10.23736/S0392-9590.18.04046-4. View

Georgiadis G, Antoniou G, Argyriou C, Schoretsanitis N, Nikolopoulos E, Kapoulas K . Correlation of Baseline Plasma and Inguinal Connective Tissue Metalloproteinases and Their Inhibitors With Late High-Pressure Endoleak After Endovascular Aneurysm Repair: Long-term Results. J Endovasc Ther. 2019; 26(6):826-835. DOI: 10.1177/1526602819871963. View

Lu H, Shih C, Sung S, Wu A, Cheng T, Lin Y . Galectin-3 as a Biomarker for Stratifying Abdominal Aortic Aneurysm Size in a Taiwanese Population. Front Cardiovasc Med. 2021; 8:663152. PMC: 8200414. DOI: 10.3389/fcvm.2021.663152. View

Lesiak M, Augusciak-Duma A, Stepien K, Fus-Kujawa A, Botor M, Sieron A . Searching for new molecular markers for cells obtained from abdominal aortic aneurysm. J Appl Genet. 2021; 62(3):487-497. PMC: 8357660. DOI: 10.1007/s13353-021-00641-4. View

Urbonavicius S, Urbonaviciene G, Honore B, Henneberg E, Vorum H, Lindholt J . Potential circulating biomarkers for abdominal aortic aneurysm expansion and rupture--a systematic review. Eur J Vasc Endovasc Surg. 2008; 36(3):273-80. DOI: 10.1016/j.ejvs.2008.05.009. View

10.

Eilenberg W, Zagrapan B, Bleichert S, Ibrahim N, Knobl V, Brandau A . Histone citrullination as a novel biomarker and target to inhibit progression of abdominal aortic aneurysms. Transl Res. 2021; 233:32-46. DOI: 10.1016/j.trsl.2021.02.003. View

11.

Li T, Wang T, Zhao X . Profiles of immune infiltration in abdominal aortic aneurysm and their associated marker genes: a gene expression-based study. Braz J Med Biol Res. 2021; 54(11):e11372. PMC: 8427746. DOI: 10.1590/1414-431X2021e11372. View

12.

Li T, Yang C, Jing J, Sun L, Yuan Y . Granzyme K - A novel marker to identify the presence and rupture of abdominal aortic aneurysm. Int J Cardiol. 2021; 338:242-247. DOI: 10.1016/j.ijcard.2021.06.014. View

13.

Wu Z, Trenner M, Boon R, Spin J, Maegdefessel L . Long noncoding RNAs in key cellular processes involved in aortic aneurysms. Atherosclerosis. 2019; 292:112-118. PMC: 6949864. DOI: 10.1016/j.atherosclerosis.2019.11.013. View

14.

Moxon J, Ng E, Lazzaroni S, Boult M, Velu R, Fitridge R . Circulating biomarkers are not associated with endoleaks after endovascular repair of abdominal aortic aneurysms. J Vasc Surg. 2017; 67(3):770-777. DOI: 10.1016/j.jvs.2017.06.090. View

15.

Lieberg J, Wanhainen A, Ottas A, Vahi M, Zilmer M, Soomets U . Metabolomic Profile of Abdominal Aortic Aneurysm. Metabolites. 2021; 11(8). PMC: 8401627. DOI: 10.3390/metabo11080555. View

16.

de Haro J, Bleda S, Acin F . C-reactive protein predicts aortic aneurysmal disease progression after endovascular repair. Int J Cardiol. 2015; 202:701-6. DOI: 10.1016/j.ijcard.2015.09.122. View

17.

Arnaoutoglou E, Kouvelos G, Papa N, Karamoutsios A, Bouris V, Vartholomatos G . Platelet activation after endovascular repair of abdominal aortic aneurysm. Vascular. 2015; 24(3):287-94. DOI: 10.1177/1708538115596911. View

18.

Li Y, Yang D, Zheng Y . Challenges of applying circulating biomarkers for abdominal aortic aneurysm progression. Exp Biol Med (Maywood). 2021; 246(9):1054-1059. PMC: 8113738. DOI: 10.1177/1535370221992530. View

19.

Knappich C, Spin J, Eckstein H, Tsao P, Maegdefessel L . Involvement of Myeloid Cells and Noncoding RNA in Abdominal Aortic Aneurysm Disease. Antioxid Redox Signal. 2020; 33(9):602-620. PMC: 7455479. DOI: 10.1089/ars.2020.8035. View

20.

Ikoma A, Nakai M, Sato M, Sato H, Takeuchi H, Tanaka F . Changes in inflammatory, coagulopathic, and fibrinolytic responses after endovascular repair of an abdominal aortic aneurysm: relationship between fibrinogen degradation product levels and endoleaks. Jpn J Radiol. 2014; 32(6):347-55. DOI: 10.1007/s11604-014-0314-0. View